Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells
NCT02425800 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43
Last updated 2021-09-01
Summary
This pilot research trial studies the use of a human prostate tissue model to maintain and study prostate cancer stem cells. A human prostate tissue model uses leftover tissue that was removed during surgery from patients with non-cancerous enlargement of the prostate (benign prostatic hyperplasia) and may create an environment similar to the natural environment of the human body. Prostate cancer stem cells are cells that cause cancer to grow. Using real tissue to create an environment to study stem cells may help doctors learn more about how they work and how they respond to treatments.
Conditions
- Benign Prostatic Hyperplasia
- Prostate Carcinoma
Interventions
- OTHER
-
Cytology Specimen Collection Procedure
Undergo collection of tissue samples
- OTHER
-
Laboratory Biomarker Analysis
Correlative studies
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Wake Forest University Health Sciences
lead OTHER
Principal Investigators
-
Ashok K Hemal · Wake Forest University Health Sciences
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-28
- Primary Completion
- 2018-11-05
- Completion
- 2021-08-03
Countries
- United States
Study Locations
More Related Trials
-
Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate Cancer
NCT01983709 ·Status: TERMINATED ·Phase: PHASE1
-
3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer
NCT01296672 ·Status: COMPLETED ·Phase: PHASE4
-
Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer
NCT00005827 ·Status: WITHDRAWN ·Phase: PHASE1
-
Studying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154
NCT00535834 ·Status: COMPLETED
-
Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer
NCT01436214 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Surgery in Treating Patients With Prostate Cancer
NCT00002938 ·Status: COMPLETED ·Phase: PHASE2
-
Proton Radiation Therapy in Treating Patients With Prostate Cancer
NCT01045226 ·Status: TERMINATED ·Phase: NA
-
Glycosylation of Exosomes in Prostate and Urothelial Carcinoma
NCT04960956 ·Status: TERMINATED
-
Long-Term Follow-Up in Patients With Prostate Cancer After Surgery
NCT03035500 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Carbohydrate Restriction and Prostate Cancer Growth
NCT01763944 ·Status: COMPLETED ·Phase: NA
-
Genistein in Treating Patients With Prostate Cancer
NCT01126879 ·Status: TERMINATED ·Phase: PHASE2
-
PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer
NCT05805371 ·Status: RECRUITING ·Phase: PHASE1
-
Using Serum Parathyroid Hormones and Calcium to Improve Prostate Cancer Diagnosis
NCT02397629 ·Status: COMPLETED
-
Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
NCT01145508 ·Status: TERMINATED ·Phase: PHASE2
-
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
NCT06733350 ·Status: RECRUITING ·Phase: PHASE4
-
Study of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer
NCT02025010 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer
NCT00005028 ·Status: COMPLETED ·Phase: PHASE2
-
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
NCT01325311 ·Status: COMPLETED ·Phase: PHASE2
-
Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program
NCT00035217 ·Status: COMPLETED
-
Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer
NCT00582140 ·Status: COMPLETED ·Phase: PHASE1
-
Daily, Long-Term Intermittent Fasting for the Prevention of PSA-Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy
NCT04288336 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Perifosine in Treating Patients With Recurrent Prostate Cancer
NCT00058214 ·Status: TERMINATED ·Phase: PHASE2
-
Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy
NCT00058266 ·Status: TERMINATED ·Phase: PHASE2
-
Nutrition and Prostate Cancer
NCT03532308 ·Status: TERMINATED ·Phase: PHASE3
-
Plasma and Urine Samples From Patients With Hormone-Refractory Prostate Cancer Enrolled on Clinical Trials CALGB-9480 or CALGB-9583
NCT00898833 ·Status: TERMINATED